132 related articles for article (PubMed ID: 38590673)
21. The role and diagnostic accuracy of serology for COVID-19.
Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
Javed W; Abidi SHB; Baqar JB
BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
Saeed AY; Assafi MS; Othman HE; Shukri HM
J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil.
Santos CC; de M Lima FW; Magno L; Soares F; Ferraz D; Grangeiro A; Zucchi EM; Préau M; Mabire X; Matos HRSS; Dourado I;
BMC Public Health; 2023 Jan; 23(1):61. PubMed ID: 36624484
[TBL] [Abstract][Full Text] [Related]
25. High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran.
Balou HA; Yaghubi Kalurazi T; Joukar F; Hassanipour S; Shenagari M; Khoshsorour M; Mansour-Ghanaei F
J Environ Public Health; 2021; 2021():9081491. PubMed ID: 34691195
[TBL] [Abstract][Full Text] [Related]
26. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
[TBL] [Abstract][Full Text] [Related]
27. Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?
Krygier R; Stępień PM; Zarębska-Michaluk D
Int J Occup Med Environ Health; 2021 May; 34(2):203-209. PubMed ID: 33734216
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China.
Duan S; Zhou M; Zhang W; Shen J; Qi R; Qin X; Yu H; Zhou C; Hu Q; Yu XJ
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008975. PubMed ID: 33411805
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
Meireles P; Amaro J; Pinto da Costa J; Lopes MM; Varandas T; Norton P; Guimarães JT; Severo M; Barros H
Occup Environ Med; 2021 Sep; 78(9):648-653. PubMed ID: 34193594
[TBL] [Abstract][Full Text] [Related]
31. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
Chen J; Niu Z; Li H; Tang D; Zhang P
Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of IgM and IgG Against SARS-CoV-2 after Two Doses of Pfizer-BioNTech COVID-19 Vaccine in Women with Breast Cancer.
Almehmadi M; Salih MM; Shafie A; Alsharif A; Alsiwiehr N; El-Askary A; Alzahrani K; Al-Hazmi A; Aljuaid A; Abdulazziz O; Almalki AA; Allahyani M; Eed E; Alharbi AM; Halawi M; Allam HH; Abutawil H; Alosimi E; Gharib AF
Clin Lab; 2022 Nov; 68(11):. PubMed ID: 36378000
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 Virus: A Systematic Review and Meta-Analysis Study.
Fathi M; Vakili K; Sayehmiri F; Mohamadkhani A; Ghanbari R; Hajiesmaeili M; Rezaei-Tavirani M
Iran J Immunol; 2021 Mar; 18(1):34-46. PubMed ID: 33787512
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
40. SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy.
Marchi S; Lanave G; Camero M; Dapporto F; Manenti A; Benincasa L; Acciavatti A; Brogi G; Viviani S; Montomoli E; Trombetta CM
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
